The increase in intracellular calcium is influenced by cyclic nucleotides (cAMP and cGMP) content, which rating is governed by phosphodiesterases (PDEs) activity.Despite it has been demonstrated a beneficial effect of PDEs inhibitors in different pathological conditions involving SKM, not much is known on the role exerted by cAMP-cGMP/PDEs axis in human SKM contractility. Here, we show that Ssulfhydration of PDEs modulates human SKM contractility in physiological and pathological conditions. Having previously demonstrated that, in the rare human syndrome Malignant Hyperthermia (MH), there is an overproduction of hydrogen sulfide (H2S) within SKM contributing to hyper-contractility, here we have used MH negative diagnosed biopsies (MHN) as healthy SKM, and MH susceptible diagnosed biopsies (MHS) as a pathological model of SKM hypercontractility. The study has been performed on MHS and MHN human biopsies after diagnosis has been made and on primary SKM cells derived from both MHN and MHS biopsies. Our data demonstrate that in normal conditions PDEs are S-sulfhydrated in both quadriceps' biopsies and primary SKM cells. This post translational modification (PTM) negatively regulates PDEs activity with consequent increase of both cAMP and cGMP levels. In hypercontractile biopsies, due to an excessive H2S content, there is an enhanced Ssulfhydration of PDEs that further increases cyclic nucleotides levels contributing to SKM hyper-contractility. Thus, the identification of a new endogenous PTM modulating PDEs activity represents an advancement in SKM physiopathology understanding.

Phosphodiesterases S-sulfhydration contributes to human skeletal muscle function / Vellecco, Valentina; Panza, Elisabetta; Bibli Sofia, Iris; Casillo, GIAN MARCO; Raucci, Federica; Manzo, ONORINA LAURA; Smimmo, Martina; Villani, Romolo; Cavezza Maria, Rosaria; Fleming, Ingrid; D'EMMANUELE DI VILLA BIANCA, Roberta; Maione, Francesco; Cirino, Giuseppe; Bucci, Mariarosaria. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 177:(2022), pp. 106108-106117. [10.1016/j.phrs.2022.106108]

Phosphodiesterases S-sulfhydration contributes to human skeletal muscle function

Vellecco Valentina;Panza Elisabetta;Casillo Gian Marco;Raucci Federica;Manzo Onorina Laura;Smimmo Martina;d'Emmanuele di Villa Bianca Roberta;Maione Francesco;Cirino Giuseppe;Bucci Mariarosaria
2022

Abstract

The increase in intracellular calcium is influenced by cyclic nucleotides (cAMP and cGMP) content, which rating is governed by phosphodiesterases (PDEs) activity.Despite it has been demonstrated a beneficial effect of PDEs inhibitors in different pathological conditions involving SKM, not much is known on the role exerted by cAMP-cGMP/PDEs axis in human SKM contractility. Here, we show that Ssulfhydration of PDEs modulates human SKM contractility in physiological and pathological conditions. Having previously demonstrated that, in the rare human syndrome Malignant Hyperthermia (MH), there is an overproduction of hydrogen sulfide (H2S) within SKM contributing to hyper-contractility, here we have used MH negative diagnosed biopsies (MHN) as healthy SKM, and MH susceptible diagnosed biopsies (MHS) as a pathological model of SKM hypercontractility. The study has been performed on MHS and MHN human biopsies after diagnosis has been made and on primary SKM cells derived from both MHN and MHS biopsies. Our data demonstrate that in normal conditions PDEs are S-sulfhydrated in both quadriceps' biopsies and primary SKM cells. This post translational modification (PTM) negatively regulates PDEs activity with consequent increase of both cAMP and cGMP levels. In hypercontractile biopsies, due to an excessive H2S content, there is an enhanced Ssulfhydration of PDEs that further increases cyclic nucleotides levels contributing to SKM hyper-contractility. Thus, the identification of a new endogenous PTM modulating PDEs activity represents an advancement in SKM physiopathology understanding.
2022
Phosphodiesterases S-sulfhydration contributes to human skeletal muscle function / Vellecco, Valentina; Panza, Elisabetta; Bibli Sofia, Iris; Casillo, GIAN MARCO; Raucci, Federica; Manzo, ONORINA LAURA; Smimmo, Martina; Villani, Romolo; Cavezza Maria, Rosaria; Fleming, Ingrid; D'EMMANUELE DI VILLA BIANCA, Roberta; Maione, Francesco; Cirino, Giuseppe; Bucci, Mariarosaria. - In: PHARMACOLOGICAL RESEARCH. - ISSN 1043-6618. - 177:(2022), pp. 106108-106117. [10.1016/j.phrs.2022.106108]
File in questo prodotto:
File Dimensione Formato  
Vellecco Panza et al.pdf

accesso aperto

Descrizione: articolo principale
Tipologia: Versione Editoriale (PDF)
Licenza: Dominio pubblico
Dimensione 4.11 MB
Formato Adobe PDF
4.11 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/875595
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact